These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16329454)

  • 1. [New discoveries about the fragile X syndrome complicate genetic counseling. More symptoms than earlier known caused by the disease gene].
    Kristoffersson U; Wahlström J; Lynöe N
    Lakartidningen; 2005 Oct 31-Nov 6; 102(44):3232-4, 3236. PubMed ID: 16329454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal function of ovaries in women carriers of premutation in the FMR1 gene].
    Lisik MZ
    Wiad Lek; 2007; 60(5-6):265-9. PubMed ID: 17966892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fragile X chromosomes and fragile X syndrome].
    Boonen SE; Grønskov K; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3727-8. PubMed ID: 17069739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X and reproduction.
    Martin JR; Arici A
    Curr Opin Obstet Gynecol; 2008 Jun; 20(3):216-20. PubMed ID: 18460934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in research on the fragile X syndrome.
    Mazzocco MM
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):96-106. PubMed ID: 10899802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure: a phenotypic expression of fragile X premutation.
    Holoch K; Stein Q; Flanagan J; Hansen K
    S D Med; 2008 Jan; 61(1):13, 15. PubMed ID: 18323308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
    Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
    Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X premutation with atypical symptoms at onset.
    Cellini E; Forleo P; Ginestroni A; Nacmias B; Tedde A; Bagnoli S; Mascalchi M; Sorbi S; Piacentini S
    Arch Neurol; 2006 Aug; 63(8):1135-8. PubMed ID: 16908740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia.
    Adams SA; Steenblock KJ; Thibodeau SN; Lindor NM
    J Neurogenet; 2008; 22(1):77-92. PubMed ID: 18363164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
    Berry-Kravis E; Potanos K; Weinberg D; Zhou L; Goetz CG
    Ann Neurol; 2005 Jan; 57(1):144-7. PubMed ID: 15622531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.